Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

14 Approvals To Look Out For In Q3

Jul 10 2018

• By Alex Shimmings

Money — Waiting To Start Selling

Related Content

EMA Panel Finalises Safety Probe Into Richter’s Fibroid Drug Esmya

May 17 2018

Animals Rule: SIGA’s Smallpox Drug Tecovirimat Sails Through US FDA Panel

May 02 2018

Agios' IDH Inhibitors Show Their Mettle At ASH

Dec 12 2017

Shire CEO Says Lanadelumab Results Vindicate Dyax Buy, M&A Strategy

May 19 2017

Mogamulizumab Nips At Adcetris’s Heels In CTCL After New Results

Apr 12 2017

Progenics On Way To The FDA With Second Product Offering Azedra

Mar 31 2017

Another Antibiotic Success Story as Tetraphase's Eravacycline Meets Goal

Jul 26 2017

Teva Pushes CGRP Timeline Back To End Of 2018

May 03 2018

Dova’s Doptelet Gets First-To-Market Edge In Thrombocytopenia, Ahead Of Shionogi

May 22 2018

Teva's CGRP Inhibitor Fails In Chronic Cluster Headaches, Continues In Episodic

Jun 15 2018

New EU Approval Further Boost For Tagrisso As Threats Recede

Jun 11 2018

Japan First To Approve Omarigliptin, Lusutrombopag

Sep 30 2015

FDA Reversal Gives Amicus Renewed Hope For US Oral Fabry Launch

Jul 11 2017

Related Companies

Agios Pharmaceuticals, Inc.

Kyowa Kirin Co., Ltd.

Seagen Inc.

AbbVie Inc.

Neurocrine Biosciences, Inc.

Amicus Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Tetraphase Pharmaceuticals, Inc.

Eli Lilly and Company

Novartis AG

Amgen, Inc.

Teva Pharmaceutical Industries Ltd.

Celltrion, Inc.

Progenics Pharmaceuticals, Inc.

Pfizer Inc.

AstraZeneca PLC

Insmed Incorporated

SIGA Technologies, Inc

Shionogi & Co. Ltd.

Dova Pharmaceuticals, Inc.

Allergan plc

Additional Topics

Approvals Cancer Gynecology & Urology Metabolic Disorders Neurology Cardiovascular Infectious Diseases BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.